Arthrocare's Buyout Value Looks Bloated
- Loading Comments...
Since early March, when Arthrocare(ARTC Quote) suddenly decided to explore "strategic alternatives," the company has seemed eager to ink a deal.
On paper at least, Arthrocare looks like an attractive takeout target. The Austin, Texas-based medical device maker boasts a remarkable growth rate, especially in the lucrative spine space, and it has been reporting a solid profit for the past nine years.
Late last year, however, with Arthrocare riding high on yet another record quarter, short-sellers took direct aim at the company. At the time, Arthrocare had seen its spine sales almost double because of soaring demand for its disposable "SpineWands." But short-sellers claimed that Arthrocare had been leaning heavily on its DiscoCare division -- a firm suspected of supplying SpineWands for unnecessary surgeries -- to drive up that demand. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,328.89 | 1,102.47 | 2,211.69 | 35.46 |
Oil *
73.88
|
|
UP
20.63
|
UP
6.40
|
UP
31.64
|
UP
0.59
|
10 Yr
3.55%
SPDR Gold
108.95
|
|
+0.20%
|
+0.58%
|
+1.45%
|
+1.69%
|
Data delayed 20 minutes |


Connect with TheStreet